Algorithm for lamotrigine dose adjustment before, during, and after pregnancy

Acta Neurologica Scandinavica

Volumn 126, Issue 1, 2012, Pages

  Sabers, A ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Epilepsy; Lamotrigine; Pregnancy; Seizure deterioration

Indexed keywords

LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT;

CODING ALGORITHM; CONCEPTION; DETERIORATION; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; NOTE; PREGNANCY; PUERPERIUM; RISK; SEIZURE; STANDARD;

ADULT; ALGORITHMS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; TRIAZINES;

EID: 84861747517     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01627.x     Document Type: Note

References (15)

1. Tomson T, Battino D, Bonizzoni E et al.Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17.
2. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008;81:1-13.
3. EURAP Study Group. Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry. Epilepsia 2009;50:2305-9.
4. Sabers A, Tomson T. Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 2009;22:157-61.
5. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants?Clin Pharmacokinet 2000;38:191-204.
6. Sabers A, Petrenaite V. Seizure frequency in pregnant women treated with lamotrigine monotherapy. Epilepsia 2009;50:2163-66.
7. Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001;47:151-4.
8. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66:354-60.
9. Pennell PB, Peng L, Newport DJ et al.Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008;70:2130-6.
10. Petrenaite V, Sabers A, Hansen-Schwartz J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 2005;65:185-8.
11. De Haan GJ, Edelbroek P, Segers J et al.Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004;63:571-3.
12. Sabers A. Influences on seizure activity in pregnant women with epilepsy. Epilepsy Behav 2009;15:230-4.
13. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41:709-13.
14. Ohman I, Beck O, Vitols S, Tomson T. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 2008;49:1075-80.
15. Tomson T, Luef G, Sabers A, Pittschieler S, Ohman I. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives. Neurology 2006;67:1297-9.